Doxorubicin and m-AMSA induced DNA damage in blast cells from AML patients

This publication has 12 references indexed in Scilit:

• Comparison of intracellular drug retention, DNA damage and cytotoxicity of derivatives of doxorubicin and daunorubicin in a human colon adenocarcinoma cell line (LoVo)
  Biochemical Pharmacology, 1989
• Intracellular doxorubicin concentrations and drug-induced DNA damage in a human colon adenocarcinoma cell line and in a drug-resistant subline
  Biochemical Pharmacology, 1988
• The Human Hematopoietic Colony-Stimulating Factors
  Science, 1987
• DNA topoisomerase II: A primer on the enzyme and its unique role as a multidrug target in cancer chemotherapy
  Pharmacology & Therapeutics, 1987
• Clonogenic cells in acute myeloblastic leukemia
  Blood, 1986
• Loss of viability and induction of DNA damage in human leukemic myeloblasts and lymphocytes by m-AMSA
  Cancer Chemotherapy and Pharmacology, 1986
• Topoisomerase-II activity in human leukemic and lymphoblastoid cells
  Biochemical and Biophysical Research Communications, 1985
• DNA topoisomerase II as a target of antineoplastic drug therapy
  Cancer and Metastasis Reviews, 1985
• Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino)methanesulfon-m-anisidide and adriamycin
  Biochemistry, 1981
• Relationship between cytotoxicity and dna strand break-age produced by adriamycin and other intercalating agents
  International Journal of Radiation Oncology*Biology*Physics, 1979